1. Home
  2. CLST vs GNTA Comparison

CLST vs GNTA Comparison

Compare CLST & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catalyst Bancorp Inc.

CLST

Catalyst Bancorp Inc.

HOLD

Current Price

$17.06

Market Cap

67.3M

Sector

N/A

ML Signal

HOLD

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$1.49

Market Cap

69.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLST
GNTA
Founded
1922
2014
Country
United States
Italy
Employees
N/A
9
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.3M
69.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CLST
GNTA
Price
$17.06
$1.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.5K
62.6K
Earning Date
04-30-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
171.79
N/A
EPS
0.15
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$111.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.40
$0.55
52 Week High
$18.16
$10.00

Technical Indicators

Market Signals
Indicator
CLST
GNTA
Relative Strength Index (RSI) 51.84 48.42
Support Level $16.37 $1.30
Resistance Level $17.19 $1.70
Average True Range (ATR) 0.18 0.14
MACD -0.04 -0.01
Stochastic Oscillator 32.73 60.42

Price Performance

Historical Comparison
CLST
GNTA

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It operates in one reportable segment, which generates income principally from interest on loans and investment securities, as well as from fees charged in connection with various loan and deposit services.

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: